Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2014

01-04-2014 | Research Article

Knowledge, attitudes, and practices of community pharmacists on generic medicines in Qatar

Authors: Ahmed Awaisu, Nadir Kheir, Mohamed Izham Mohamed Ibrahim, Maguy El-Hajj, Huda Hazi, Nada Khudair, Raja Barazi

Published in: International Journal of Clinical Pharmacy | Issue 2/2014

Login to get access

Abstract

Background The practice of generic medicines prescribing, dispensing and substitution in developing countries has been controversial among healthcare professionals, particularly due to issues on quality, safety and efficacy. These controversies are as a result of inter-country differences in policies and laws as well as individualized knowledge and attitudes of pharmacists pertaining to generic medicines. Objective This study primarily aims to assess the knowledge, attitudes, and practices of community pharmacists in Qatar towards generic medicines. Setting Community pharmacy settings throughout the State of Qatar. Method A cross-sectional study using a pretested paper-based survey was conducted among a random sample of community pharmacists in Qatar. The data were analyzed using IBM-SPSS® version 20. Both descriptive and inferential statistical analyses were applied. Main outcome measure Knowledge, attitudes, and practices of generic medicines pertaining to regulatory standards, safety, efficacy, quality, and future policies. Results A total of 160 surveys were distributed to community pharmacists of which 118 were returned (response rate, 74 %). The mean total score of generic medicines knowledge among the pharmacists was 6.8 ± 1.6 (maximum possible score was 10). Years of practice as well as place of obtaining academic degree did not influence knowledge score. Approximately 72 % of the pharmacists supported generic substitution for brand name drugs in all cases where a generic medicine is available and the majority (93 %) agreed that pharmacists should be given generic substitution right. Nearly 61 % of the pharmacists considered lack of proven bioequivalence to original brands as an important barrier for selecting generic medicines and 55 % rated “lack of policy for directing the practice of generic medicine” as an important barrier. Conclusion In order to enhance the quality use of and to promote the practice of generic medicines in Qatar, an educational program should be implemented. A national generic medicine policy and guidelines are warranted in the State of Qatar.
Literature
1.
go back to reference Cumming J, Mays N, Daubé J. How New Zealand has contained expenditure on drugs. BMJ. 2010;340:c2441PubMedCrossRef Cumming J, Mays N, Daubé J. How New Zealand has contained expenditure on drugs. BMJ. 2010;340:c2441PubMedCrossRef
2.
go back to reference Tordoff JM, Norris PT, Reith DM. Managing prices for hospital pharmaceuticals: a successful strategy for New Zealand? Value Health. 2005;8(3):201–8PubMedCrossRef Tordoff JM, Norris PT, Reith DM. Managing prices for hospital pharmaceuticals: a successful strategy for New Zealand? Value Health. 2005;8(3):201–8PubMedCrossRef
3.
go back to reference Tordoff JM, Norris PT, Reith DM. Price management and its impact on hospital pharmaceutical expenditure and the availability of medicines in New Zealand hospitals. Value Health. 2008;11(7):1214–26PubMedCrossRef Tordoff JM, Norris PT, Reith DM. Price management and its impact on hospital pharmaceutical expenditure and the availability of medicines in New Zealand hospitals. Value Health. 2008;11(7):1214–26PubMedCrossRef
9.
go back to reference Adelman C, Norris J. Generic medicines are not substandard medicines. Lancet. 2002;359(9314):1351–2CrossRef Adelman C, Norris J. Generic medicines are not substandard medicines. Lancet. 2002;359(9314):1351–2CrossRef
11.
go back to reference Kanavos P. Do generics offer significant savings to the UK National Health Service? Curr Med Res Opin. 2007;23(1):105–16PubMedCrossRef Kanavos P. Do generics offer significant savings to the UK National Health Service? Curr Med Res Opin. 2007;23(1):105–16PubMedCrossRef
12.
go back to reference Karim SA, Pillai G, Ziqubu-Page T, Cassimjee M, Morar M. Potential savings from generic prescribing and generic substitution in South Africa. Health Policy Plan. 1996;11(2):198–205PubMedCrossRef Karim SA, Pillai G, Ziqubu-Page T, Cassimjee M, Morar M. Potential savings from generic prescribing and generic substitution in South Africa. Health Policy Plan. 1996;11(2):198–205PubMedCrossRef
13.
go back to reference King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croat Med J. 2002;43(4):462–9PubMed King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croat Med J. 2002;43(4):462–9PubMed
14.
15.
go back to reference Perry G. The European generic pharmaceutical market in review: 2006 and beyond. J Generic Med. 2006;4(1):4–14CrossRef Perry G. The European generic pharmaceutical market in review: 2006 and beyond. J Generic Med. 2006;4(1):4–14CrossRef
16.
go back to reference Simoens S. Generic medicine pricing in Europe: current issues and future perspective. J Med Econ. 2008;11(1):171–5PubMedCrossRef Simoens S. Generic medicine pricing in Europe: current issues and future perspective. J Med Econ. 2008;11(1):171–5PubMedCrossRef
17.
go back to reference Garattini L, Tediosi F. A comparative analysis of generics markets in five European countries. Health Policy. 2000;51(3):149–62PubMedCrossRef Garattini L, Tediosi F. A comparative analysis of generics markets in five European countries. Health Policy. 2000;51(3):149–62PubMedCrossRef
18.
go back to reference Birkett DJ. Generics-equal or not? Austr Prescriber. 2003;26(4):85–7 Birkett DJ. Generics-equal or not? Austr Prescriber. 2003;26(4):85–7
19.
go back to reference Hassali A, Stewart K, Kong D. Quality use of generic medicines. Austr Prescriber. 2004;27:80–1 Hassali A, Stewart K, Kong D. Quality use of generic medicines. Austr Prescriber. 2004;27:80–1
20.
21.
go back to reference Babar Z-U-D, Grover P, Stewart J, Hogg M, Short L, Seo HG, et al. Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand. Res Soc Adm Pharm. 2011;7(3):294–305CrossRef Babar Z-U-D, Grover P, Stewart J, Hogg M, Short L, Seo HG, et al. Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand. Res Soc Adm Pharm. 2011;7(3):294–305CrossRef
22.
go back to reference Campbell M, Bateman DN, Lee A, Smith J, Beaney A. The pros and cons of generic medicines. Pharmacoeconomics. 1995;8(4):362–3PubMedCrossRef Campbell M, Bateman DN, Lee A, Smith J, Beaney A. The pros and cons of generic medicines. Pharmacoeconomics. 1995;8(4):362–3PubMedCrossRef
23.
go back to reference Carroll NV, Wolfgang AP. Risks, benefits, and generic substitution. J Consum Aff. 1991;25(1):110–21CrossRef Carroll NV, Wolfgang AP. Risks, benefits, and generic substitution. J Consum Aff. 1991;25(1):110–21CrossRef
24.
go back to reference Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther. 2003;25(11):2875–90PubMedCrossRef Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther. 2003;25(11):2875–90PubMedCrossRef
25.
go back to reference Barba Z-U-D, Awaisu A. Evaluating community pharmacists’ perceptions and practices on generic medicines: a pilot study from Peninsular Malaysia. J Generic Med. 2008;5(4):315–30CrossRef Barba Z-U-D, Awaisu A. Evaluating community pharmacists’ perceptions and practices on generic medicines: a pilot study from Peninsular Malaysia. J Generic Med. 2008;5(4):315–30CrossRef
26.
go back to reference Carroll NV, Siridhara C, Fincham JE. Perceived risks and pharmacists’ generic substitution behavior. J Consum Aff. 1986;20(1):36–47CrossRef Carroll NV, Siridhara C, Fincham JE. Perceived risks and pharmacists’ generic substitution behavior. J Consum Aff. 1986;20(1):36–47CrossRef
27.
go back to reference Carroll NV, Wolfgang AP. Inherent risk and market acceptance of generic drug products. J Health Care Mark. 1989;9(4):48–51PubMed Carroll NV, Wolfgang AP. Inherent risk and market acceptance of generic drug products. J Health Care Mark. 1989;9(4):48–51PubMed
28.
go back to reference Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240–9PubMedCrossRef Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240–9PubMedCrossRef
29.
go back to reference Cameron A, Mantel-Teeuwisse AK, Leufkens HGM, Laing RO. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value Health. 2012;15(5):664–73PubMedCrossRef Cameron A, Mantel-Teeuwisse AK, Leufkens HGM, Laing RO. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value Health. 2012;15(5):664–73PubMedCrossRef
30.
go back to reference Kaplan WA, Ritz LS, Vitello M, Wirtz VJ. Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000–2010. Health Policy. 2012;106(3):211–24PubMedCrossRef Kaplan WA, Ritz LS, Vitello M, Wirtz VJ. Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000–2010. Health Policy. 2012;106(3):211–24PubMedCrossRef
31.
go back to reference Mott DA, Cline RR. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care. 2002;40(8):662–74PubMedCrossRef Mott DA, Cline RR. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care. 2002;40(8):662–74PubMedCrossRef
32.
go back to reference Jamshed SQ, Ibrahim MIM, Hassali MA, Babar ZUD, Alkalami R, Siddiqui MJ. Do hospital pharmacists in Pakistan understand the concept of generic medicines? a mixed-method approach. Res Soc Adm Pharm. 2012;8(6):e17CrossRef Jamshed SQ, Ibrahim MIM, Hassali MA, Babar ZUD, Alkalami R, Siddiqui MJ. Do hospital pharmacists in Pakistan understand the concept of generic medicines? a mixed-method approach. Res Soc Adm Pharm. 2012;8(6):e17CrossRef
33.
go back to reference Jamshed SQ, Ibrahim MIM, Hassali MA, Babar ZUD, Alkalami R, Siddiqui MJ. Do community pharmacists understand the concept of generic medicines? A quantitative insight from Karachi, Pakistan. Res Social Adm Pharm. 2012;8(6):e16–7CrossRef Jamshed SQ, Ibrahim MIM, Hassali MA, Babar ZUD, Alkalami R, Siddiqui MJ. Do community pharmacists understand the concept of generic medicines? A quantitative insight from Karachi, Pakistan. Res Social Adm Pharm. 2012;8(6):e16–7CrossRef
34.
go back to reference Center for Drug Evaluation and Research FDA. Guidance for industry. Bioavailability and bioequivalence studies for orally administered drug products—general consideration. Rockville, MD: U.S. Department of Health and Human Services; 2003 [cited 2013 13 March]; http://www.fda.gov/downloads/Drugs/…/Guidances/ucm070124.pdf Center for Drug Evaluation and Research FDA. Guidance for industry. Bioavailability and bioequivalence studies for orally administered drug products—general consideration. Rockville, MD: U.S. Department of Health and Human Services; 2003 [cited 2013 13 March]; http://​www.​fda.​gov/​downloads/​Drugs/​…/Guidances/ucm070124.pdf
35.
go back to reference Al-Gedadi NA, Hassali MA. Pharmacists’ views on generic medicines: a review of the literature. J Generic Med. 2008;5(3):209–18CrossRef Al-Gedadi NA, Hassali MA. Pharmacists’ views on generic medicines: a review of the literature. J Generic Med. 2008;5(3):209–18CrossRef
36.
go back to reference Chong CP, Hassali MA, Bahari MB, Shafie AA. Evaluating community pharmacists’ perceptions of future generic substitution policy implementation: a national survey from Malaysia. Health Policy. 2010;94(1):68–75PubMedCrossRef Chong CP, Hassali MA, Bahari MB, Shafie AA. Evaluating community pharmacists’ perceptions of future generic substitution policy implementation: a national survey from Malaysia. Health Policy. 2010;94(1):68–75PubMedCrossRef
37.
go back to reference Chong CP, Hassali MA, Bahari MB, Shafie AA. Exploring community pharmacists’ views on generic medicines: a nationwide study from Malaysia. Int J Clin Pharm. 2011;33(1):124–31PubMedCrossRef Chong CP, Hassali MA, Bahari MB, Shafie AA. Exploring community pharmacists’ views on generic medicines: a nationwide study from Malaysia. Int J Clin Pharm. 2011;33(1):124–31PubMedCrossRef
38.
go back to reference Chong CP, Hassali MA, Bahari MB, Shafie AA. Generic medicine substitution practices among community pharmacists: a nationwide study from Malaysia. J Public Health. 2011;19(1):81–90CrossRef Chong CP, Hassali MA, Bahari MB, Shafie AA. Generic medicine substitution practices among community pharmacists: a nationwide study from Malaysia. J Public Health. 2011;19(1):81–90CrossRef
39.
go back to reference Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A web-based survey on Australian community pharmacists’ perceptions and practices of generic substitution. J Generic Med. 2010;7(4):342–53CrossRef Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A web-based survey on Australian community pharmacists’ perceptions and practices of generic substitution. J Generic Med. 2010;7(4):342–53CrossRef
40.
go back to reference Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy. 2011;99(2):139–48PubMedCrossRef Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy. 2011;99(2):139–48PubMedCrossRef
41.
go back to reference Hassali M, Kong D, Stewart K. Generic medicines: perceptions of community pharmacists in Melbourne, Australia. J Pharm Financ Econ Pol. 2005;14(3):27CrossRef Hassali M, Kong D, Stewart K. Generic medicines: perceptions of community pharmacists in Melbourne, Australia. J Pharm Financ Econ Pol. 2005;14(3):27CrossRef
42.
go back to reference Bearden WO, Mason JB. Physician and pharmacist perceptions of generic drugs. Ind Mark Manag. 1979;8(1):63–8CrossRef Bearden WO, Mason JB. Physician and pharmacist perceptions of generic drugs. Ind Mark Manag. 1979;8(1):63–8CrossRef
43.
go back to reference Granlund D. Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals? Soc Sci Med. 2009;69(11):1643–50PubMedCrossRef Granlund D. Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals? Soc Sci Med. 2009;69(11):1643–50PubMedCrossRef
44.
go back to reference Paraponaris A, Verger P, Desquins B, Villani P, Bouvenot G, Rochaix L, et al. Delivering generics without regulatory incentives?: Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names. Health Policy. 2004;70(1):23–32PubMedCrossRef Paraponaris A, Verger P, Desquins B, Villani P, Bouvenot G, Rochaix L, et al. Delivering generics without regulatory incentives?: Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names. Health Policy. 2004;70(1):23–32PubMedCrossRef
45.
go back to reference Crawford P, Feely M, Guberman A, Kramer G. Are there potential problems with generic substitution of antiepileptic drugs? A review of issues. Seizure. 2006;15(3):165–76PubMedCrossRef Crawford P, Feely M, Guberman A, Kramer G. Are there potential problems with generic substitution of antiepileptic drugs? A review of issues. Seizure. 2006;15(3):165–76PubMedCrossRef
46.
go back to reference Borgheini G. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugs. Clin Ther. 2003;25(6):1578–92PubMedCrossRef Borgheini G. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugs. Clin Ther. 2003;25(6):1578–92PubMedCrossRef
47.
go back to reference Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease. JAMA. 2008;300(21):2514–26PubMedCentralPubMedCrossRef Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease. JAMA. 2008;300(21):2514–26PubMedCentralPubMedCrossRef
48.
go back to reference Andersson K, Sonesson C, Petzold M, Carlsten A, Lönnroth K. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiol Drug Saf. 2005;14(5):341–8PubMedCrossRef Andersson K, Sonesson C, Petzold M, Carlsten A, Lönnroth K. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiol Drug Saf. 2005;14(5):341–8PubMedCrossRef
49.
go back to reference Allenet B, Barry H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharm World Sci. 2003;25(5):197–202PubMedCrossRef Allenet B, Barry H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharm World Sci. 2003;25(5):197–202PubMedCrossRef
50.
go back to reference Vallès J-A, Barreiro M, Cereza G, Ferro J–J, Martınez MJ, et al. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy. 2003;65(3):269–75PubMedCrossRef Vallès J-A, Barreiro M, Cereza G, Ferro J–J, Martınez MJ, et al. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy. 2003;65(3):269–75PubMedCrossRef
Metadata
Title
Knowledge, attitudes, and practices of community pharmacists on generic medicines in Qatar
Authors
Ahmed Awaisu
Nadir Kheir
Mohamed Izham Mohamed Ibrahim
Maguy El-Hajj
Huda Hazi
Nada Khudair
Raja Barazi
Publication date
01-04-2014
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 2/2014
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-013-9909-2

Other articles of this Issue 2/2014

International Journal of Clinical Pharmacy 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.